Pfizer Sanctioned Over Shoddy Witness Testimony

Law360, New York (January 26, 2011, 7:23 PM EST) -- A federal court has sanctioned Pfizer Inc. for a witness testimony violation and also certified a class of direct purchasers that accuses the pharmaceutical giant and a subsidiary of using patent litigation to delay generic competition for epilepsy drug Neurontin.

Magistrate Judge Patty Shwartz of the U.S. District Court for the District of New Jersey ruled Tuesday that Pfizer and Warner-Lambert Co. failed for the second time to produce a witness sufficiently prepared to testify about their off-label use denials.

Judge Shwartz did not strike the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.